ASH HIGHLIGHTS 2023 – MULTIPLE MYELOMA ROUNDTABLE DISCUSSION: Venetoclax in Combination with Daratumumab and Dexamethasone Elicits Deep, Durable Responses in Patients with t(11;14) Multiple Myeloma
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Best of Oncology Podcast Series","authorlink":""},"src":"https:\/\/traffic.libsyn.com\/secure\/bestofoncology\/AS0FE71.mp3?dest-id=1101521","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202311\/090a51-8209-9524-b316f9_800.png"},"title":"ASH HIGHLIGHTS 2023 \u2013 MULTIPLE MYELOMA ROUNDTABLE DISCUSSION: Venetoclax in Combination with Daratumumab and Dexamethasone Elicits Deep, Durable Responses in Patients with t(11;14) Multiple Myeloma","link":"javascript:;","id":"item-99854073"}]
